Drug recall · May 14, 2014
Metoprolol Succinate Extended-Release Tablets recall
Why: Failed Dissolution Specifications: failure of dissolution test observed at nine month time point.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 30-count bottle, Rx only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC., 20 Waterview Blvd., Parsippany, NJ 07054, USA; NDC 64679-735-09, UPC 3 64679 73509 1.
- Lots / codes
Lot #: LN10686, LN10687, LN10688, LN10707, LN10708, Exp 02/15
- Quantity
- 109,744 bottles
- Company
- Wockhardt Usa Inc., Parsippany, NJ
- Distribution
- Nationwide
- Initiated
- April 1, 2014 · Voluntary: Firm initiated
- Classified
- May 2, 2014
- Reported
- May 14, 2014
- Ended
- May 12, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Metoprolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.